1
|
Chiu PF, Mok A, Leow J, Zhang K, Chiang C, Hsieh P, Lam W, Tsang W, Chan H, Fan Y, Lin T, Hayashi T, Kamoi K, Uno H, Letran J, Zhu Y, Wang H, Chan T, Huang C, Zhu G, Wu H, Chiong E, Ng C, Shoji S. The role of systematic biopsy in the era of MRI guided prostate biopsy in a multi-centre Asian cohort. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00347-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
2
|
Park J, Lam W, Chalmers DR, Velez JC. Immobilization-associated hypercalcemia in the hospital setting: a cohort study. Am J Med Sci 2023. [DOI: 10.1016/s0002-9629(23)00504-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
|
3
|
Poon DMC, Chan CK, Chan K, Chu WH, Kwong PWK, Lam W, Law KS, Lee EKC, Liu PL, Sze HCK, Wong JHM, Chan ESY. Recommendations for the management of advanced and metastatic renal cell carcinoma: joint consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology. Hong Kong Med J 2022; 28:475-481. [PMID: 35815480 DOI: 10.12809/hkmj219727] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
INTRODUCTION Kidney cancer, primarily renal cell carcinoma (RCC), ranks among the top 10 most common malignancies in the male population of Hong Kong. In 2019, members of two medical societies in Hong Kong formed an expert panel to establish a set of consensus statements for the management of metastatic RCC. On 22 June 2021, the same panel met to review recent evidence and reassess their positions regarding the management of advanced and metastatic RCC, with the aim of providing recommendations for physicians in Hong Kong. PARTICIPANTS The panel included 12 experts (6 clinical oncologists and 6 urologists) who had extensive experience managing patients with RCC in Hong Kong. EVIDENCE The panel reviewed randomised controlled trials, observational studies, systematic reviews/meta-analyses, and international clinical guidelines to address key clinical questions that were identified before the meeting. CONSENSUS PROCESS In total, 15 key clinical questions were identified before the meeting, covering the surgical and systemic treatment of advanced or metastatic clear cell, sarcomatoid, and non-clear cell RCCs. At the meeting, the panellists voted on these questions, then discussed relevant evidence and practical considerations. CONCLUSIONS The treatment landscape for advanced and metastatic RCC continues to evolve. More immune checkpoint inhibitor (ICI)-based combination regimens will be indicated for the treatment of metastatic clear cell RCC. There is increasing evidence concerning the benefit of adjuvant ICI treatment for resected advanced RCC. This article summarises recent evidence and expert insights regarding a series of key clinical questions about the management of advanced and metastatic RCC.
Collapse
Affiliation(s)
- D M C Poon
- Hong Kong Society of Uro-Oncology, Hong Kong
| | - C K Chan
- Hong Kong Urological Association, Hong Kong
| | - K Chan
- Hong Kong Society of Uro-Oncology, Hong Kong
| | - W H Chu
- Hong Kong Urological Association, Hong Kong
| | - P W K Kwong
- Hong Kong Society of Uro-Oncology, Hong Kong
| | - W Lam
- Hong Kong Urological Association, Hong Kong
| | - K S Law
- Hong Kong Society of Uro-Oncology, Hong Kong
| | - E K C Lee
- Hong Kong Society of Uro-Oncology, Hong Kong
| | - P L Liu
- Hong Kong Urological Association, Hong Kong
| | - H C K Sze
- Hong Kong Society of Uro-Oncology, Hong Kong
| | - J H M Wong
- Hong Kong Urological Association, Hong Kong
| | - E S Y Chan
- Hong Kong Urological Association, Hong Kong
| |
Collapse
|
4
|
Lai CKC, Lam W, Tsang KY, Cheng FWT, Wong MCS. COVID-19 pandemic after Omicron. Hong Kong Med J 2022; 28:196-198. [PMID: 35765729 DOI: 10.12809/hkmj215130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/15/2023] Open
Affiliation(s)
- C K C Lai
- Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
| | - W Lam
- Chiron Medical, Hong Kong
| | - K Y Tsang
- Specialist in Infectious Disease, Private Practice, Hong Kong
| | - F W T Cheng
- Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong
| | - M C S Wong
- JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
- Editor-in-Chief, Hong Kong Medical Journal
| |
Collapse
|
5
|
Mok A, Leow J, Chiang C, Hsieh P, Lam W, Tsang W, Chan H, Law M, Leung C, Li C, So H, Liu P, Au W, Fan Y, Lin T, Teoh J, Tsu J, Ng C, Wu H, Tan T, Chiong E, Huang C, Chiu PF. Role of PSA density in prediction of significant prostate cancer among Asian men with MRI-guided biopsies: A multicenter evaluation. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00705-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
6
|
de Vries H, Lee H, Lam W, Djajadiningrat R, Ottenhof S, Roussel E, Kroon B, de Jong I, Oliveira P, Alnajjar H, Albersen M, Muneer A, Sangar V, Parnham A, Ayres B, Watkin N, Horenblas S, Stuiver M, Brouwer O. Clinicopathologic predictors of finding additional inguinal lymph node metastases in penile cancer patients following positive dynamic sentinel node biopsy: a European multicentre evaluation. BJU Int 2021; 130:126-132. [DOI: 10.1111/bju.15678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2021] [Revised: 11/24/2021] [Accepted: 12/11/2021] [Indexed: 11/28/2022]
Affiliation(s)
- H.M. de Vries
- Department of Urology Netherlands Cancer Institute Amsterdam Netherlands
| | - H.J. Lee
- Department of Urology St. George University Hospital NHS foundation trust London United Kingdom
| | - W. Lam
- Department of Urology St. George University Hospital NHS foundation trust London United Kingdom
| | | | - S.R. Ottenhof
- Department of Urology Netherlands Cancer Institute Amsterdam Netherlands
| | - E. Roussel
- Department of Urology University Hospital Leuven Leuven Belgium
| | - B.K. Kroon
- Department of Urology Rijnstate Hospital Arnhem Netherlands
| | - I.J. de Jong
- Department of Urology University Medical Centre Groningen Groningen Netherlands
| | - P. Oliveira
- Department of Pathology The Christie NHS foundation trust Manchester United Kingdom
| | - H.M. Alnajjar
- Department of Urology and NIHR Biomedical Research Centre University College London Hospitals NHS foundation trust London United Kingdom
| | - M. Albersen
- Department of Urology University Hospital Leuven Leuven Belgium
| | - A. Muneer
- Department of Urology and NIHR Biomedical Research Centre University College London Hospitals NHS foundation trust London United Kingdom
- Division of Surgery and Interventional Science University College London Hospitals NHS foundation trust London United Kingdom
| | - V. Sangar
- Department of Urology The Christie NHS foundation trust London United Kingdom
- Manchester Academic Health Sciences Centre University of Manchester United Kingdom
| | - A. Parnham
- Department of Urology The Christie NHS foundation trust London United Kingdom
| | - B. Ayres
- Department of Urology St. George University Hospital NHS foundation trust London United Kingdom
| | - N. Watkin
- Department of Urology St. George University Hospital NHS foundation trust London United Kingdom
| | - S. Horenblas
- Department of Urology Netherlands Cancer Institute Amsterdam Netherlands
| | - M.M. Stuiver
- Department of Clinical Epidemiology Amsterdam University Medical Centres location AMC Amsterdam Netherlands
| | - O.R. Brouwer
- Department of Urology Netherlands Cancer Institute Amsterdam Netherlands
| |
Collapse
|
7
|
De Vries H, Lee H, Lam W, Djajadiningrat R, Ottenhof S, Roussel E, Kroon B, Jong I, Oliveira P, Alnajjar H, Albersen M, Muneer A, Sangar V, Parnham A, Ayres B, Watkin N, Horenblas S, Stuiver M, Brouwer O. Developing a predictive model for additional lymph node metastases at inguinal lymph node dissection following positive sentinel node biopsy for penile cancer: An European multicentre evaluation. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)03081-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
8
|
Lam W, Wong A, Chun S, Wong T, Hung W, Lie H, Tsang C, Ho B, Ng A, Tsu J. Prostate cancer detection, tolerability and safety of transperineal prostate biopsy under local-anaesthesia versus standard transrectal biopsy in biopsy-naïve men: A pragmatic, parallel group, randomized-controlled study. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01372-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
9
|
|
10
|
Rotimi O, Beatson K, Aderombi A, Lam W, Bajomo O, Kukreja N. Surgical consent during the COVID-19 pandemic. Ann Med Surg (Lond) 2020; 59:229-233. [PMID: 33052257 PMCID: PMC7544629 DOI: 10.1016/j.amsu.2020.10.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2020] [Accepted: 10/07/2020] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND AND AIMS During the COVID-19 pandemic, surgical practice may deviate with operative and non-operative management considered. Appropriate discussion of options with patients is paramount to quality surgical care. Intercollegiate and EAES guidelines recommend discussing and documenting risk of COVID-19 exposure in the consent process for patients undergoing surgery. MATERIALS AND METHODS Closed-loop audit of consent forms for patients undergoing emergency and elective surgical procedures. Interventions implemented included education of wider surgical teams. Data was collected during a one-week period for each cycle and analysed using Chi-squared test. RESULTS In cycle 1, 6/17 (35.3%) case notes documented discussion of COVID-19 risk. Following intervention, compliance improved to 23/29 (79.3%) cases in cycle 2 and 33/45 (73.3%) cases in cycle 3. CONCLUSION Pre-intervention, our consenting practice was non-compliant. Our interventions led to significant and sustained improvements in practice. We recommend provision of wider surgical team education to facilitate good consenting practice.
Collapse
Affiliation(s)
- O. Rotimi
- General Surgery Department, Windmill Road, Medway Maritime Hospital, Gillingham, Kent, ME7 5NY, United Kingdom
| | - K. Beatson
- General Surgery Department, Windmill Road, Medway Maritime Hospital, Gillingham, Kent, ME7 5NY, United Kingdom
| | - A. Aderombi
- General Surgery Department, Windmill Road, Medway Maritime Hospital, Gillingham, Kent, ME7 5NY, United Kingdom
| | - W. Lam
- General Surgery Department, Windmill Road, Medway Maritime Hospital, Gillingham, Kent, ME7 5NY, United Kingdom
| | - O. Bajomo
- General Surgery Department, Windmill Road, Medway Maritime Hospital, Gillingham, Kent, ME7 5NY, United Kingdom
| | - N. Kukreja
- General Surgery Department, Windmill Road, Medway Maritime Hospital, Gillingham, Kent, ME7 5NY, United Kingdom
| |
Collapse
|
11
|
Jemec B, Lam W, Hodgson SP, Jones JWM, Eckersley R, Nyamulani N, Riaz M, Fell M, Nicholas R, Bhopal R, Mendis K, Khan MRK, Sommerlad B. The governance of overseas surgical collaborations - BFIRST/BSSH. J Plast Reconstr Aesthet Surg 2020; 74:396-400. [PMID: 33051175 DOI: 10.1016/j.bjps.2020.08.022] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2019] [Revised: 06/11/2020] [Accepted: 08/01/2020] [Indexed: 11/28/2022]
Abstract
Clinical governance is the structured approach to maintaining and improving the quality of patient care and is a vital part of global surgery. BFIRST and BSSH closely collaborate with local doctors on a number of overseas projects, seeking to strengthen and develop local knowledge and skills, aiming for an independent local practice in reconstructive and upper limb surgery. Thoughts on essential requirements, improvements and pitfalls in the ethical approach to global collaboratives are presented.
Collapse
Affiliation(s)
- B Jemec
- The British Foundation for International Surgery and Training and Associates, c/o the British Association for Plastic, Reconstructive and Aesthetic Surgery Lincolns Inn Fields, WC2A 3PE, United Kingdom the BSSH is Lincolns Inn Fields, WC2A 3PE, United Kingdom.
| | - W Lam
- The British Foundation for International Surgery and Training and Associates, c/o the British Association for Plastic, Reconstructive and Aesthetic Surgery Lincolns Inn Fields, WC2A 3PE, United Kingdom the BSSH is Lincolns Inn Fields, WC2A 3PE, United Kingdom
| | - S P Hodgson
- The British Society for Surgery of the Hand Overseas Committee and Associates, United Kingdom
| | - J W M Jones
- The British Society for Surgery of the Hand Overseas Committee and Associates, United Kingdom
| | - R Eckersley
- The British Society for Surgery of the Hand Overseas Committee and Associates, United Kingdom
| | - N Nyamulani
- The British Society for Surgery of the Hand Overseas Committee and Associates, United Kingdom
| | - M Riaz
- The British Foundation for International Surgery and Training and Associates, c/o the British Association for Plastic, Reconstructive and Aesthetic Surgery Lincolns Inn Fields, WC2A 3PE, United Kingdom the BSSH is Lincolns Inn Fields, WC2A 3PE, United Kingdom
| | - M Fell
- The British Foundation for International Surgery and Training and Associates, c/o the British Association for Plastic, Reconstructive and Aesthetic Surgery Lincolns Inn Fields, WC2A 3PE, United Kingdom the BSSH is Lincolns Inn Fields, WC2A 3PE, United Kingdom
| | - R Nicholas
- The British Foundation for International Surgery and Training and Associates, c/o the British Association for Plastic, Reconstructive and Aesthetic Surgery Lincolns Inn Fields, WC2A 3PE, United Kingdom the BSSH is Lincolns Inn Fields, WC2A 3PE, United Kingdom
| | - R Bhopal
- The British Foundation for International Surgery and Training and Associates, c/o the British Association for Plastic, Reconstructive and Aesthetic Surgery Lincolns Inn Fields, WC2A 3PE, United Kingdom the BSSH is Lincolns Inn Fields, WC2A 3PE, United Kingdom
| | - Kapila Mendis
- The Lady Ridgeway Hospital for Children, Colombo, Sri Lanka.
| | - M R Karim Khan
- The British Foundation for International Surgery and Training and Associates, c/o the British Association for Plastic, Reconstructive and Aesthetic Surgery Lincolns Inn Fields, WC2A 3PE, United Kingdom the BSSH is Lincolns Inn Fields, WC2A 3PE, United Kingdom
| | - B Sommerlad
- The British Foundation for International Surgery and Training and Associates, c/o the British Association for Plastic, Reconstructive and Aesthetic Surgery Lincolns Inn Fields, WC2A 3PE, United Kingdom the BSSH is Lincolns Inn Fields, WC2A 3PE, United Kingdom
| |
Collapse
|
12
|
Nguyen Q, Coghlan K, Nagendran J, MacArthur R, Lam W. FACTORS ASSOCIATED WITH EARLY EXTUBATION AFTER CARDIAC SURGERY: A RETROSPECTIVE STUDY. Can J Cardiol 2020. [DOI: 10.1016/j.cjca.2020.07.189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
13
|
Demant D, Peden A, Lam W. An international comparison of pool lifeguard requirements and qualifications. Eur J Public Health 2020. [DOI: 10.1093/eurpub/ckaa166.1248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Drowning is one of the leading causes of the global burden of morbidity and injury-related deaths. In highly industrialised countries, death and injuries from drowning are commonly associated with recreational activities and disproportionately affect minors. In aquatic facilities, drowning is often the result of risky behaviours and management issues. Pool lifeguards are an important factor in lowering the drowning burden. However, research on lifeguard training and formal requirements is scarce.
Methods
The aim of this study was to review official and unofficial (training) requirements for pool lifeguards in 24 high-income countries. Information was extracted from (1) legislative databases, (2) publicly available information from governmental and non-governmental organisations as well as a (3) cross-sectional survey on training and employment practices sent out to specialist organisations and aquatic facilities.
Results
All jurisdictions had a minimum standard for physical fitness, swimming ability, eligible minimum age, and further training and qualification requirements. However, the depth and length of further training differed drastically between jurisdictions and many of these standards were 'de-facto' industry standards rather than legislated. Only some jurisdictions had regulations regarding visual and hearing impairments (n = 13) or infectious and chronic conditions (n = 13). Only three jurisdictions had a character requirement.
Conclusions
Pool lifeguards are an important factor in preventing injury and death from drowning and require a high-level of physical endurance, first aid and rescue knowledge as well as analytical skills to be effective. A stronger legislated regulation of pool lifeguard requirements may be effective in reducing risk of drowning.
Key messages
Pool lifeguards are an important factor in preventing injury and death from drowning and require high-level physical endurance, first aid/rescue knowledge as well as analytical skills to be effective. A stronger legislated regulation of pool lifeguard requirements may be effective in reducing risk of drowning.
Collapse
Affiliation(s)
- D Demant
- School of Public Health, Faculty of Health, University of Technology Sydney, Sydney, Australia
- School of Public Health and Social Work, Faculty of Health, Queensland University of Technology, Brisbane, Australia
| | - A Peden
- School of Public Health and Community Medicine, Faculty of M, University of New South Wales, Sydney, Australia
- College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Australia
| | - W Lam
- School of Public Health, Faculty of Health, University of Technology Sydney, Sydney, Australia
| |
Collapse
|
14
|
Hung W, Chun S, Wong T, Tsang C, Ho B, Ng A, Tsu H, Lam W. Transrectal vs. transperineal prostate biopsy under local anaesthesia: Prospective comparative analysis of cancer detection, safety and tolerability using patient-reported outcome measures at a single centre. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)34175-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
15
|
Cheung M, Ng G, Lam W. Magnetic Resonance Imaging with Spectroscopy Findings in Neonatal Nonketotic Hyperglycinaemia: A Case Report. Hong Kong Journal of Radiology 2020. [DOI: 10.12809/hkjr2017104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Affiliation(s)
- M Cheung
- Department of Radiology, Queen Mary Hospital, Pokfulam, Hong Kong
| | - G Ng
- Department of Radiology, Queen Mary Hospital, Pokfulam, Hong Kong
| | - W Lam
- Department of Radiology, Queen Mary Hospital, Pokfulam, Hong Kong
| |
Collapse
|
16
|
Goodwin T, Broda C, Opina A, Lam W, Ermis P. Initial Experience in Adults with Complex Congenital Heart Disease Treated with Sacubitril/Valsartan for Heart Failure. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.908] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
17
|
Gutierrez M, Hellmann M, Gubens M, Aggarwal C, Tan D, Felip E, Lam W, Chiu J, Lee J, Yang J, Garon E, Basso A, Ma H, Fong L, Snyder A, Yuan J, Herbst R. P1.01-107 KEYNOTE-495/KeyImPaCT: Phase 2 Biomarker-Directed Study of Pembrolizumab-Based Therapy for Non–Small Cell Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.822] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
18
|
Ng K, Sage A, Marshall E, Enfield K, Lam W. MA04.11 Biological and Prognostic Implications of the Long Non-Coding Transcriptome in Tumour-Infiltrating Immune Cells. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
19
|
Vucic E, Marshall E, Ng R, Lam S, Lam W. P2.03-24 Concurrent Aberrations in G2/M-Phase Transcriptional Programs and Genomic Gatekeepers Highlight Lung Cancer Predisposition in COPD Patients. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
20
|
Lam W, Nowak A, Chen F, Muruganandan S, Arunachalam S, Chin M, Millward M, Read C, Murray K, Creaney J, Lee Y. MA23.01 Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.691] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
21
|
Stewart G, Sage A, Martinez V, Enfield K, Lam W. P2.03-47 Deregulation of a Novel Cis-Acting lncRNA in Non-Small Cell Lung Cancer May Control HMGA1 Expression. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
22
|
Yeung D, Lam W, Leung C, Isaacowitz D. DO YOUNGER AND OLDER EMPLOYEES REACT TO INTERGENERATIONAL CONFLICTS DIFFERENTLY? Innov Aging 2018. [DOI: 10.1093/geroni/igy023.1550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- D Yeung
- City University of Hong Kong, Hong Kong, Hong Kong
| | - W Lam
- City University of Hong Kong, Hong Kong
| | - C Leung
- City University of Hong Kong, Hong Kong
| | | |
Collapse
|
23
|
|
24
|
Macaulay C, Guillaud M, Enfield K, Xu Z, Lam S, Lam W, Gallagher P. P3.09-11 Genomic Organization at Large Scales (GOALS) within Nuclei and Cell Sociology for Predicting Lung Cancer Outcomes. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1780] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
25
|
Tokar T, Pastrello C, Ramnarine V, Zhu C, Craddock K, Pikor L, Vucic E, Vary S, Shepherd F, Tsao M, Lam W, Jurisica I. P3.03-06 Differentially Expressed microRNAs in Lung Adenocarcinoma Invert Effects of Copy Number Aberrations of Prognostic Genes. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
26
|
Sage A, Stewart G, Rowbotham D, Enfield K, Marshall E, Martinez V, Anderson C, Lam W. MA24.07 A Novel cis-Acting lncRNA Controls HMGA1 Expression in Lung Adenocarcinoma. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
27
|
Minatel B, Martinez V, Sage A, Marshall E, Tokar T, Becker-Santos D, Robinson W, Jurisica I, Lam W. MA21.10 Large-Scale Discovery of Novel Human Oncofetal Transcripts in Lung. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
28
|
Nowak A, Kok P, Lesterhuis W, Hughes B, Brown C, Kao S, Karikios D, John T, Pavlakis N, O'Byrne K, Yip S, Lam W, Briscoe K, Karapetis C, Stockler M. OA08.02 DREAM - A Phase 2 Trial of Durvalumab with First Line Chemotherapy in Mesothelioma: Final Result. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.276] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
29
|
Cheema P, Liu G, Burkes R, Owen S, Yu J, Hao D, Rothenstein J, Martel S, Iqbal M, Juergens R, Lam W, Laskin J. P2.13-13 Real-World Study of Osimertinib in EGFR T790M-Mutated Non-Small Cell Lung Cancer (NSCLC): ASTRIS Canadian Cohort Analysis. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
30
|
Sage A, Ng K, Marshall E, Enfield K, Stewart G, Martin S, Minatel B, Brown C, Abraham N, Lam W. MA24.06 Long Non-Coding Rna Expression Patterns Delineate Infiltrating Immune Cells in the Lung Tumour Microenvironment. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
31
|
Dhumale SR, Barraclough TW, Stokes A, Lam W. Producing 3D printed hand models for anatomy education using cadaveric dissection: a feasibility study. ACTA ACUST UNITED AC 2018. [DOI: 10.1308/rcsbull.2018.217] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
What are the potential benefits and problems?
Collapse
Affiliation(s)
- SR Dhumale
- Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK
| | - TW Barraclough
- Stokes Research Group, Institute for Integrated Micro and Nano Systems, School of Engineering, University of Edinburgh, Edinburgh, UK
| | - A Stokes
- Stokes Research Group, Institute for Integrated Micro and Nano Systems, School of Engineering, University of Edinburgh, Edinburgh, UK
| | - W Lam
- Royal Hospital for Sick Children, Edinburgh, and St John’s Hospital, Livingstone, Edinburgh; Centre for Human Anatomy, Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK
| |
Collapse
|
32
|
Khin N, Peh W, Tham W, Lam W, Wang M, Siow T, Lim F, Tan D, Chin F, Chua E, Wang F, Ho S, Yip C. Biochemical and radiological inflammatory markers in oesophageal squamous cell carcinoma treated with radical chemoradiation. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
33
|
Johung K, Kann B, Lacy J, Stein S, Kortmansky J, Zaheer W, Cheng Y, Lam W, Liu S, Decker R, Hochster H, Higgins S. Pilot trial of YIV-906 with neoadjuvant chemoradiotherapy (CRT) in patients with locally advanced rectal cancer. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.319] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
34
|
Tam D, Leung Y, Lam W, Lai M, Yau B, Lee W, Mak Y. An electron microscopic study of human amniotic membrane derived epithelial and stromal stem cells. Cytotherapy 2018. [DOI: 10.1016/j.jcyt.2018.02.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
35
|
Poh S, Mueller S, Lam W, Teo P, Tan H. EP-1103: Tumour volume as a prognostic marker in early-stage nasopharyngeal carcinoma. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31413-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
36
|
|
37
|
Reyaldeen R, Dermedgoglou A, Collings S, Spears A, Sutcliffe S, Starmer G, Lam W. Incremental Diagnostic Role of Cardiac Magnetic Resonance in Myocardial Infarction with Non–Obstructive Coronary Arteries: Regional Far North Queensland Experience. Heart Lung Circ 2018. [DOI: 10.1016/j.hlc.2018.06.456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
38
|
Reyaldeen R, Dermedgoglou A, Nucifora J, Lam W, Brazzale A, Starmer G. Coexistence of Incidental Coronary Artery Disease in Takotsubo Cardiomyopathy: A Single Regional Centre Experience. Heart Lung Circ 2018. [DOI: 10.1016/j.hlc.2018.06.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
39
|
Rainer T, Chan S, Kwok K, Suen D, Lam W, Cocks R. Severe Trauma Presenting to the Resuscitation Room of a Hong Kong Emergency Department. HONG KONG J EMERG ME 2017. [DOI: 10.1177/102490790000700302] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Background Little is known about the epidemiology or mortality associated with trauma in Hong Kong or of its demands on the service of emergency departments. This study describes both the quantity and quality of trauma presenting to an emergency department in Hong Kong. Methods In a retrospective study conducted from January to June 1997 there were 100,000 new patient attendances at the emergency department of the Prince of Wales Hospital of which 227 trauma patients (0.002%) were triaged to the Resuscitation Room. Patient records were scrutinised for types and mechanisms of injury, times of injury and arrival at the emergency department, role of alcohol, and scored using an injury severity score. Important outcomes were mortality and duration of hospital stay. Results Data was available on 221 (97%) subjects (male to female ratio 3.7:1) of which there were 203 adults and 18 children. Blunt injury accounted for 199/215 (92.6%) cases and penetrating for 16/215 (7.4%) cases. Motor vehicle crashes accounted for 113/205 (55%) cases, falls for 47/205 (23%) cases and assault for 18/205 (9%) cases. 51/224 (23%) cases presented between the hours of midnight and 8 am. The median injury severity score (ISS) was 9 (mean 11; range 1–59). 32/227 (14%) patients died, the majority resulting from road traffic accidents or falls. Conclusion Patterns of ‘severe’ trauma in Hong Kong primarily affect male adults, include a preponderance of motor vehicle crashes and falls, and significant mortality.
Collapse
Affiliation(s)
- Th Rainer
- Prince of Wales Hospital, Accident & Emergency Medicine Academic Unit, The Chinese University of Hong Kong, Rooms G05/06, Cancer Centre, Shatin, N.T., Hong Kong
| | | | | | | | | | | |
Collapse
|
40
|
Sage A, Stewart G, Enfield K, Marshall E, Martinez V, Lam W. MA 15.14 Long Non-Coding RNA Disruption in Lung Adenocarcinoma Reveals Novel Mechanisms of Metastasis. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
41
|
Minatel B, Martinez V, Sage A, Marshall E, Ng K, Anderson C, Becker-Santos D, Robinson W, Jurisica I, Lam W. MA 15.12 Expanding the Lung Small RNA Transcriptome: Discovery of Unannotated microRNAs with Roles in Development and Tumorigenesis. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
42
|
Sage A, Stewart G, Anderson C, Rowbotham D, Enfield K, Marshall E, Martinez V, Lam W. P2.02-022 Alternative Regulation of Cancer-Associated Genes through Modulation of Long Non-Coding RNAs. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
43
|
Marshall E, Ng K, Enfield K, Martin S, Milne K, Kung S, Macaulay C, Lam W. MA 10.09 Increased T Follicular Helper Cell Infiltration in Lung Adenocarcinoma Tertiary Lymphoid Organs. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
44
|
Enterina J, Lam W. P1.02-050 Pan-Can Analysis of miRNAs at the Imprinted Chromosome 14q32 Locus Reveals a Unique Pattern of Deregulation in NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
45
|
Franks E, Halvorsen E, Melesse E, Unni A, Collier J, Oh M, Lam V, Krystal G, English J, Lam W, Lam S, Abraham N, Bennewith K, Lockwood W. MA 05.12 Oncogenic Drivers Induce Production of CCL5 to Recruit Regulatory T-Cells Early in Lung Cancer Progression. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
46
|
Martinez V, Ng K, Marshall E, Sage A, Minatel B, Jurisica I, Lam W. P1.02-006 Arsenic Promotes Persistent Alterations in the Lung PiRNA Transcriptome to Target Epigenetic Pathways. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
47
|
Judd A, Zangerle R, Touloumi G, Warszawski J, Meyer L, Dabis F, Mary Krause M, Ghosn J, Leport C, Wittkop L, Reiss P, Wit F, Prins M, Bucher H, Gibb D, Fätkenheuer G, Julia DA, Obel N, Thorne C, Mocroft A, Kirk O, Stephan C, Pérez-Hoyos S, Hamouda O, Bartmeyer B, Chkhartishvili N, Noguera-Julian A, Antinori A, d’Arminio Monforte A, Brockmeyer N, Prieto L, Rojo Conejo P, Soriano-Arandes A, Battegay M, Kouyos R, Mussini C, Tookey P, Casabona J, Miró JM, Castagna A, Konopnick D, Goetghebuer T, Sönnerborg A, Quiros-Roldan E, Sabin C, Teira R, Garrido M, Haerry D, de Wit S, Miró JM, Costagliola D, d’Arminio-Monforte A, Castagna A, del Amo J, Mocroft A, Raben D, Chêne G, Judd A, Pablo Rojo C, Barger D, Schwimmer C, Termote M, Wittkop L, Campbell M, Frederiksen CM, Friis-Møller N, Kjaer J, Raben D, Salbøl Brandt R, Berenguer J, Bohlius J, Bouteloup V, Bucher H, Cozzi-Lepri A, Dabis F, d’Arminio Monforte A, Davies MA, del Amo J, Dorrucci M, Dunn D, Egger M, Furrer H, Grabar S, Guiguet M, Judd A, Kirk O, Lambotte O, Leroy V, Lodi S, Matheron S, Meyer L, Miro JM, Mocroft A, Monge S, Nakagawa F, Paredes R, Phillips A, Puoti M, Rohner E, Schomaker M, Smit C, Sterne J, Thiebaut R, Thorne C, Torti C, van der Valk M, Wittkop L, Tanser F, Vinikoor M, Macete E, Wood R, Stinson K, Garone D, Fatti G, Giddy J, Malisita K, Eley B, Fritz C, Hobbins M, Kamenova K, Fox M, Prozesky H, Technau K, Sawry S, Benson CA, Bosch RJ, Kirk GD, Boswell S, Mayer KH, Grasso C, Hogg RS, Richard Harrigan P, Montaner JSG, Yip B, Zhu J, Salters K, Gabler K, Buchacz K, Brooks JT, Gebo KA, Moore RD, Moore RD, Rodriguez B, Horberg MA, Silverberg MJ, Thorne JE, Rabkin C, Margolick JB, Jacobson LP, D’Souza G, Klein MB, Rourke SB, Rachlis AR, Cupido P, Hunter-Mellado RF, Mayor AM, John Gill M, Deeks SG, Martin JN, Patel P, Brooks JT, Saag MS, Mugavero MJ, Willig J, Eron JJ, Napravnik S, Kitahata MM, Crane HM, Drozd DR, Sterling TR, Haas D, Rebeiro P, Turner M, Bebawy S, Rogers B, Justice AC, Dubrow R, Fiellin D, Gange SJ, Anastos K, Moore RD, Saag MS, Gange SJ, Kitahata MM, Althoff KN, Horberg MA, Klein MB, McKaig RG, Freeman AM, Moore RD, Freeman AM, Lent C, Kitahata MM, Van Rompaey SE, Crane HM, Drozd DR, Morton L, McReynolds J, Lober WB, Gange SJ, Althoff KN, Abraham AG, Lau B, Zhang J, Jing J, Modur S, Wong C, Hogan B, Desir F, Liu B, You B, Cahn P, Cesar C, Fink V, Sued O, Dell’Isola E, Perez H, Valiente J, Yamamoto C, Grinsztejn B, Veloso V, Luz P, de Boni R, Cardoso Wagner S, Friedman R, Moreira R, Pinto J, Ferreira F, Maia M, Célia de Menezes Succi R, Maria Machado D, de Fátima Barbosa Gouvêa A, Wolff M, Cortes C, Fernanda Rodriguez M, Allendes G, William Pape J, Rouzier V, Marcelin A, Perodin C, Tulio Luque M, Padgett D, Sierra Madero J, Crabtree Ramirez B, Belaunzaran P, Caro Vega Y, Gotuzzo E, Mejia F, Carriquiry G, McGowan CC, Shepherd BE, Sterling T, Jayathilake K, Person AK, Rebeiro PF, Giganti M, Castilho J, Duda SN, Maruri F, Vansell H, Ly PS, Khol V, Zhang FJ, Zhao HX, Han N, Lee MP, Li PCK, Lam W, Chan YT, Kumarasamy N, Saghayam S, Ezhilarasi C, Pujari S, Joshi K, Gaikwad S, Chitalikar A, Merati TP, Wirawan DN, Yuliana F, Yunihastuti E, Imran D, Widhani A, Tanuma J, Oka S, Nishijima T, Na S, Choi JY, Kim JM, Sim BLH, Gani YM, David R, Kamarulzaman A, Syed Omar SF, Ponnampalavanar S, Azwa I, Ditangco R, Uy E, Bantique R, Wong WW, Ku WW, Wu PC, Ng OT, Lim PL, Lee LS, Ohnmar PS, Avihingsanon A, Gatechompol S, Phanuphak P, Phadungphon C, Kiertiburanakul S, Sungkanuparph S, Chumla L, Sanmeema N, Chaiwarith R, Sirisanthana T, Kotarathititum W, Praparattanapan J, Kantipong P, Kambua P, Ratanasuwan W, Sriondee R, Nguyen KV, Bui HV, Nguyen DTH, Nguyen DT, Cuong DD, An NV, Luan NT, Sohn AH, Ross JL, Petersen B, Cooper DA, Law MG, Jiamsakul A, Boettiger DC, Ellis D, Bloch M, Agrawal S, Vincent T, Allen D, Smith D, Rankin A, Baker D, Templeton DJ, O’Connor CC, Thackeray O, Jackson E, McCallum K, Ryder N, Sweeney G, Cooper D, Carr A, Macrae K, Hesse K, Finlayson R, Gupta S, Langton-Lockton J, Shakeshaft J, Brown K, Idle S, Arvela N, Varma R, Lu H, Couldwell D, Eswarappa S, Smith DE, Furner V, Smith D, Cabrera G, Fernando S, Cogle A, Lawrence C, Mulhall B, Boyd M, Law M, Petoumenos K, Puhr R, Huang R, Han A, Gunathilake M, Payne R, O’Sullivan M, Croydon A, Russell D, Cashman C, Roberts C, Sowden D, Taing K, Marshall P, Orth D, Youds D, Rowling D, Latch N, Warzywoda E, Dickson B, Donohue W, Moore R, Edwards S, Boyd S, Roth NJ, Lau H, Read T, Silvers J, Zeng W, Hoy J, Watson K, Bryant M, Price S, Woolley I, Giles M, Korman T, Williams J, Nolan D, Allen A, Guelfi G, Mills G, Wharry C, Raymond N, Bargh K, Templeton D, Giles M, Brown K, Hoy J. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study. Clin Infect Dis 2017; 65:1316-1326. [PMID: 28531260 PMCID: PMC5850623 DOI: 10.1093/cid/cix480] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2017] [Accepted: 05/19/2017] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND We compared Kaposi sarcoma (KS) risk in adults who started antiretroviral therapy (ART) across the Asia-Pacific, South Africa, Europe, Latin, and North America. METHODS We included cohort data of human immunodeficiency virus (HIV)-positive adults who started ART after 1995 within the framework of 2 large collaborations of observational HIV cohorts. We present incidence rates and adjusted hazard ratios (aHRs). RESULTS We included 208140 patients from 57 countries. Over a period of 1066572 person-years, 2046 KS cases were diagnosed. KS incidence rates per 100000 person-years were 52 in the Asia-Pacific and ranged between 180 and 280 in the other regions. KS risk was 5 times higher in South African women (aHR, 4.56; 95% confidence intervals [CI], 2.73-7.62) than in their European counterparts, and 2 times higher in South African men (2.21; 1.34-3.63). In Europe, Latin, and North America KS risk was 6 times higher in men who have sex with men (aHR, 5.95; 95% CI, 5.09-6.96) than in women. Comparing patients with current CD4 cell counts ≥700 cells/µL with those whose counts were <50 cells/µL, the KS risk was halved in South Africa (aHR, 0.53; 95% CI, .17-1.63) but reduced by ≥95% in other regions. CONCLUSIONS Despite important ART-related declines in KS incidence, men and women in South Africa and men who have sex with men remain at increased KS risk, likely due to high human herpesvirus 8 coinfection rates. Early ART initiation and maintenance of high CD4 cell counts are essential to further reducing KS incidence worldwide, but additional measures might be needed, especially in Southern Africa.
Collapse
|
48
|
Abstract
Despite progressive treatments with tandem stem-cell transplantation, patients with incurable myeloma eventually succumb to relapsed or refractory disease if left untreated. Promising agents such as proteasome inhibitors and immunomodulating imide drugs (imids), including the newer-generation agent pomalidomide, in combination with lower-dose dexamethasone, have been shown to be effective and to significantly improve and prolong survival in pretreated patients. Although the incidence of pomalidomide hypersensitivity reaction (hsr) in this class of drugs is not as well known, we have documented cutaneous toxicity (grade 3 by the Common Terminology Criteria for Adverse Events, version 4) in 2 separate cases (not yet published). Because the imids are chemically, structurally, and pharmacologically similar, it is not unreasonable to consider possible cross-reactivity in pomalidomide recipients who developed hsr when receiving previous lines of imids. As a patient's advocate, it is only prudent to provide a responsible, and yet practical, means to better address cross-sensitivity for patients. Intervention with the use of a rapid desensitization program (rdp) as a preventive measure should be introduced before initiating pomalidomide. Such a proactive measure for the patient's safety will ensure a smooth transition into pomalidomide treatment. A hsr can be either related or non-related to immunoglobulin E. As imids become an essential treatment backbone for myeloma and other plasma-cell diseases, an increasing number of patients could experience skin and other life-threatening toxicities, resulting in unnecessary discontinuation of these life-prolonging agents. An extemporaneously prepared pomalidomide suspension developed at our centre enables patients to undergo rdp safely. Patients enjoy a good quality of life and clinical response after the rdp procedure.
Collapse
Affiliation(s)
- J T Seki
- Department of Pharmacy, Princess Margaret Cancer Centre, University Health Network.,Leslie Dan Faculty of Pharmacy, University of Toronto; and
| | - N Sakurai
- Department of Pharmacy, Princess Margaret Cancer Centre, University Health Network
| | - W Lam
- Department of Pharmacy, Princess Margaret Cancer Centre, University Health Network
| | - D E Reece
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON
| |
Collapse
|
49
|
Lee WI, Watson A, Chand R, Lam W, Cook M. CPID 4: A CASE OF RECURRENT ONYCHOMYCOSIS WITHOUT AUTOIMMUNITY. Intern Med J 2017. [DOI: 10.1111/imj.4_13580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- W-I Lee
- Department of Immunology; Canberra Hospital, ACT Australia
| | - A Watson
- Department of Infectious Diseases; Canberra Hospital, ACT Australia
| | - R Chand
- Centre for Personalised Immunology; Australian National University; ACT Australia
| | - W Lam
- Centre for Personalised Immunology; Australian National University; ACT Australia
| | - M Cook
- Department of Immunology; Canberra Hospital, ACT Australia
- Centre for Personalised Immunology; Australian National University; ACT Australia
| |
Collapse
|
50
|
Vincent MD, Breadner D, Cripps MC, Jonker DJ, Klimo P, Biagi JJ, Lam W, O'Connell A, Whiston F, Stitt L, Welch SA. Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer. ACTA ACUST UNITED AC 2017; 24:e261-e268. [PMID: 28874896 DOI: 10.3747/co.24.3516] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
BACKGROUND Combination chemotherapy is associated with improved outcomes in trials of selected fit patients with advanced colorectal cancer (acrc). For older or less-fit patients, combination chemotherapy is associated with greater toxicity and less benefit. Capecitabine monotherapy is a reasonable option for those patients, but the optimal dose remains controversial. METHODS A multicentre phase i/ii trial of reduced-dose capecitabine (2000 mg/m2, days 1-14 every 21 days) was conducted in 221 patients representing one or more of the following subsets: age greater than 65 years (n = 167), Eastern Cooperative Oncology Group (ecog) performance status of 1 or greater (n = 139), elevated lactate dehydrogenase (ldh) (n = 105), or prior pelvic radiation (n = 54). Based on phase i results, patients with prior pelvic radiation received capecitabine 750 mg/m2 twice daily. The goal was to ascertain efficacy in a design that was unlikely to cause high levels of toxicity. RESULTS Median age in the patient cohort was 72 years. A median of 5 and a mean of 8 capecitabine cycles were given (range: 0-50 cycles). Grade 3 or 4 toxicity occurred in 25% of patients during the first 3 cycles (8.1% hand-foot syndrome, 7.7% diarrhea). The response rate was 13.6%, with a 69.7% disease control rate. Median progression-free survival (pfs) was 5.6 months. Post progression, 56 patients received further capecitabine monotherapy (median of 4 additional cycles). Median overall survival duration for the patients was 14.3 months. Median survival was significantly higher for those who, at baseline, had an ecog performance status of 0 (compared with 1 or more) and normal ldh (compared with elevated ldh). CONCLUSIONS Toxicity is less with dose-reduced capecitabine than with historical full-dose capecitabine, with only a small trade-off in efficacy, seen as a lower objective response rate. The improved tolerability could lead to an increased number of cycles of therapy, and pfs appears to be consistently higher at the lower dose. Those observations should, in the absence of a head-to-head clinical trial, be viewed as compelling evidence that 1000 mg/m2, or even 750 mg/m2, twice daily is an appropriate dose in elderly or frail patients with acrc.
Collapse
Affiliation(s)
- M D Vincent
- London Regional Cancer Program, London, ON.,Schulich School of Medicine and Dentistry, London, ON
| | - D Breadner
- London Regional Cancer Program, London, ON.,Schulich School of Medicine and Dentistry, London, ON
| | - M C Cripps
- Department of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON
| | - D J Jonker
- Department of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON
| | - P Klimo
- Medical Oncology, Lions Gate Hospital, North Vancouver, BC
| | - J J Biagi
- Department of Oncology, Queen's University, Kingston, ON
| | - W Lam
- Burnaby Hospital Cancer Centre, Burnaby, BC
| | | | - F Whiston
- London Regional Cancer Program, London, ON
| | - L Stitt
- London Regional Cancer Program, London, ON
| | - S A Welch
- London Regional Cancer Program, London, ON.,Schulich School of Medicine and Dentistry, London, ON
| |
Collapse
|